Revvity | PKI - Ebitda





Ebitda Veränderung Datum
Agilent USD 577M 77M 2026-06
Align Technology USD 232.86M 3.72M 2026-06
Bio Techne USD 115.94M 763K 2026-06
Bio-Rad Laboratories USD 595.3M 1.23B 2026-06
Bruker USD 143.2M 33.2M 2026-06
Celltrion KRW 25.72B 6.08B 2026-06
Charles River Laboratories USD 272.95M 43.14M 2026-06
Cspc Pharmaceutical CNY 2.19B 21.88M 2024-12
Danaher USD 2.1B 257M 2026-09
Dentsply International USD 190M 61M 2026-06
Deva Holding AS TRY 882.9M 201.7M 2023-09
Dianthus Therapeutics USD -46.46M 6.27M 2026-03
Divis Laboratories Ltd INR 12.62B 3.28B 2026-06
Edwards Lifesciences USD 555.6M 485.5M 2026-03
Illumina USD 330M 80M 2026-06
Intuitive Surgical USD 1.2B 147.7M 2026-06
IQVIA Holdings USD 1.03B 38M 2026-09
Kangmei Pharma CNY -12.72M 30.02M 2026-03
Knight Therapeutics CAD 24.45M 3.46M 2025-12
Laboratorios Farma EUR 34.94M 102.95M 2025-06
Laboratory Of America USD 767.7M 162.1M 2026-06
Malin Corporation EUR -1.1M 200K 2024-12
Medical Developments International AUD 1.78M 3.78M 2024-12
Mesa Laboratories USD 9.58M 1.47M 2024-09
Mettler Toledo International USD 322.64M 43.66M 2026-06
Myriad Genetics USD 14.3M 4M 2025-12
Neuren Pharmaceuticals AUD 11.14M 165.56M 2025-12
OraSure Technologies USD -17.7M 4.06M 2025-12
Organigram Holdings CAD -4.76M 10.02M 2026-03
Pacific Biosciences Of California USD -35.4M 5.78M 2025-09
Pharma Mar EUR 700K 2.01M 2026-06
Qiagen NV USD 207.66M 59.56M 2026-06
Quest Diagnostics USD 627M 21M 2026-09
Quidel USD 129.3M 20.6M 2026-06
Repligen USD 43.84M 70K 2026-09
Revvity USD 228.18M 44.73M 2026-06
Sartorius EUR 279.9M 600K 2026-09
Sino Biopharmaceutical CNY 2.59B 1.57B 2024-12
Thermo Fisher Scientific USD 3.79B 244M 2026-09
Tilray USD 8.36M 1.82M 2025-09
Waters USD 712M 545M 2026-06
Zealand Pharma A/S -379M 348.47M 2026-03
Zhangzhou Pientzehuang Pharmaceutical CNY 882.7M 351.1M 2026-03